Postdoctoral researcher in antiviral drug discovery - Solna

Endast för registrerade medlemmar Solna, Sverige

för 3 timmar sedan

Default job background

Job summary

You want to contribute to better health for all?

We encourage you to apply if you have expertise in molecular biology computational chemistry or their intersection.

This postdoctoral researcher position offers an exciting opportunity join our interdisciplinary group at Karolinska Institutet discover novel antivirals targeting emerging infectious diseases.
Lorem ipsum dolor sit amet
, consectetur adipiscing elit. Nullam tempor vestibulum ex, eget consequat quam pellentesque vel. Etiam congue sed elit nec elementum. Morbi diam metus, rutrum id eleifend ac, porta in lectus. Sed scelerisque a augue et ornare.

Donec lacinia nisi nec odio ultricies imperdiet.
Morbi a dolor dignissim, tristique enim et, semper lacus. Morbi laoreet sollicitudin justo eget eleifend. Donec felis augue, accumsan in dapibus a, mattis sed ligula.

Vestibulum at aliquet erat. Curabitur rhoncus urna vitae quam suscipit
, at pulvinar turpis lacinia. Mauris magna sem, dignissim finibus fermentum ac, placerat at ex. Pellentesque aliquet, lorem pulvinar mollis ornare, orci turpis fermentum urna, non ullamcorper ligula enim a ante. Duis dolor est, consectetur ut sapien lacinia, tempor condimentum purus.
Få full tillgång

Få tillgång till alla högkvalificerade tjänster och få ditt drömjobb.



Liknande jobb

  • Endast för registrerade medlemmar Solna

    We are Pelago Bioscience – committed to accelerating preclinical drug discovery and development for better human health.Pelago Bioscience is a specialized contract research organisation (CRO) that offers biologically relevant assays to progress our customers' drug discovery progr ...

  • Endast för registrerade medlemmar Solna

    The Department of Oncology-Pathology conducts basic, translational and clinical research and educational activities related to cancer. · Improved understanding of cancer processes and mechanisms for cancer drug efficacy and resistance is therefore urgently needed. Pär Nordlund's ...